FDA Mandates New Warnings for Opioid and Benzodiazepines

In a statement released on September 1, 2016 (FDA Black Box Warning), the Food and Drug Administration (FDA) announced that “after an extensive review of the latest scientific evidence, it is requiring class-wide changes to drug labeling, including patient information, to help inform health care providers and patients of the serious risks associated with the […]...Read more

Opioids in the Life of the MSA… Coming Soon

In a statement released on June 7, 2016, the National Alliance of Medicare Set-Aside Professionals (NAMSAP) announced the 2nd in a series of webinars focused on opioid drugs in the Medicare Set Aside.  The details of the release can be found at http://www.businesswire.com/news/home/20160607005395/en.  Background Since the creation of NAMSAP’s Evidence Based Medicine Committee in 2014, opioid use […]...Read more

FDA Approves Generic Release of Abilify

The U.S. Food and Drug Administration (FDA) approved the first AB-rated generics to Bristol-Myers Squibb and Otsuka’s Abilify® (aripiprazole) tablets, an atypical antipsychotic drug commonly used for treating schizophrenia and bipolar disorder. The agency approved generics from Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals and Torrent Pharmaceuticals. At least one manufacturer, Teva, announced the launch of […]...Read more

Managing Chronic Pain in Older Adults

According to the ACPA (American Chronic Pain Association) Resource Guide to Chronic Pain Management, “persistent or chronic pain is prevalent in older adults.” “Nearly one third of all prescribed medications are for patients over the age of 65 years.   More than thirty percent of hospital admissions among the elderly may be linked to an adverse drug related […]...Read more

Why Workers’ Comp Claims Drag On and On

Any employer who has dealt with legacy claims understands the financial strain it can cause.  Does the term ‘creeping catastrophic claims’ resonate?  When you look below the surface, there are a multitude of reasons for a  workers’ compensation claim to stay open for an extended period of time. Inadequate training, inappropriate handling at the beginning of the claim,  too many claims […]...Read more

CMS Releases Workers’ Compensation Medicare Set-Aside Arrangement (WCMSA) Reference Guide

On March, 29, CMS announced the release of a new Workers’ Compensation Medicare Set-Aside Arrangement (WCMSA) Reference Guide. The new guide has been posted and is available in the Downloads section of the CMS Workers’ Compensation Agency Services site at http://www.cms.gov/Medicare/Coordination-of-Benefits/WorkersCompAgencyServices/Downloads/March-29-2013-WCMSA-Reference-Guide-Version-13.pdf. The WCMSA Reference Guide was created to consolidate information currently found within the Workers’ […]...Read more